跳至主要内容
临床试验/JPRN-UMIN000048778
JPRN-UMIN000048778尚未招募未知

Investigation of improvement of sarcopenia by suppression of hyperammonemia with rifaximin. - Investigation of improvement of sarcopenia by suppression of hyperammonemia with rifaximin.

Iwate Medical University School of Medicine0 个研究点目标入组 20 人开始时间: 2022年8月28日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with liver cancer in more advanced stage than BCLC-C stage 2) Patients who will be treated for hepatocellular carcinoma within the study period. 3) Patients with serious bone or muscle disease or cardiac, pulmonary, renal, or cerebrovascular disease. 4) Pregnant or lactating women and patients who may or intend to become pregnant.

研究者

发起方
Iwate Medical University School of Medicine

相似试验